Yeastar Celebrates 15 Years of Elevating and Transforming SME Communications
XIAMEN, China and DALLAS, April 1, 2021 /PRNewswire/ — Yeastar (www.yeastar.com), the world’s leading provider…
XIAMEN, China and DALLAS, April 1, 2021 /PRNewswire/ — Yeastar (www.yeastar.com), the world’s leading provider…
TOKYO, April 1, 2021 /PRNewswire/ — Leading Japanese medical VR company Jolly Good Inc. has…
MARIETTA, Ga., April 1, 2021 /PRNewswire-PRWeb/ — DataPoints released its first quarterly client financial psychology…
Security Cameras with AI will be the smart city norm for applications such as intelligent…
LJUBLJANA, Slovenia, April 1, 2021 /PRNewswire/ — Trace Alliance is pleased to announce the new…
NEW YORK, April 1, 2021 /PRNewswire/ — DeFine Art has completed the biggest video NFT…
DANVILLE, Calif., Apr. 1, 2021 /PRNewswire-PRWeb/ — Glance Inc today announced AI Sparks for their top-ranked…
NACKA STRAND, Sweden, April 1, 2021 /PRNewswire/ — Hexagon AB, a global leader in sensor,…
SOLNA, Sweden, April 1, 2021 /PRNewswire/ — Loomis’ Annual Report and Sustainability Report for 2020…
Designed to affordably scale as a business grows, new tiered offering of the OptimalCloud IAM…
KIELPIN, Poland, April 01, 2021 (GLOBE NEWSWIRE) — Celon Pharma S.A. today announced the successful…
Basel, Switzerland, April 01, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing…
Allschwil, Switzerland – April 1, 2021 Idorsia Ltd (SIX: IDIA) today issued the formal Notice…
– Applications are supported by positive PROTECTIVE-2 Phase 3 data demonstrating that plinabulin in combination…
SAN DIEGO, March 31, 2021 (GLOBE NEWSWIRE) — Solid tumors comprise about 90% of all…
HALIFAX, Nova Scotia, March 31, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) — Applied Molecular Transport Inc. (Nasdaq:…
COLUMBUS, Ohio, March 31, 2021 (GLOBE NEWSWIRE) — Green Growth Brands Inc. (CSE: GGB) (OTCQB:…
FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or…
TORONTO, CHICAGO and MONTREAL, March 31, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company”…